ARCHIVES

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI Last Month Are Listed

August 29, 2003

Investigators Present Latest Data On Immunologic Control of Tumors

June 1, 1975

Byrd Seeks Federal Tar-Nicotine Limit

October 22, 1976

CCOP Applications Total 110(At Least), Plus 25 from Research Bases; All 57 Survivors Try Again

November 21, 1986

In Brief: Gregory Curt Nominated DCT Deputy DCC Seeks Occupational Cancer, Prevention Branch Chiefs

October 26, 1984

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

June 27, 2014